NCT03987061

MOTIV Bioresorbable Scaffold in BTK Artery Disease

Physician-initiated Trial Investigating the MOTIV™ Bioresorbable Scaffold (Reva Medical) for the Treatment of Below-The-Knee Artery Disease

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: Dr. Sabrina Overhagen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this clinical evaluation is to evaluate the immediate and long-term (up to 36 months) outcome of the MOTIV™ Bioresorbable Scaffold (Reva Medical) in a controlled prospective investigation for the treatment of patients with rest pain or minor tissue loss (CLI) due to the presence of lesions of max 100mm in length at the level of the below-the-knee arteries.

Conditions

• Peripheral Arterial Disease
• Critical Limb Ischemia

Interventions

Type	Name	Description
DEVICE	MOTIV BVS	MOTIVS BVS in below-the-knee artery disease

Timeline

• Start date: 2019-09-05
• Primary completion: 2022-07-01
• Completion: 2024-07-01
• First posted: 2019-06-14
• Last updated: 2023-03-17

Locations

8 sites across 2 countries: Austria, Germany